CS2 Flag-Smad3 Citations (9)
Originally described in: A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.Kretzschmar M, Doody J, Timokhina I, Massague J Genes Dev. 1999 Apr 1. 13(7):804-16. PubMed Journal
Articles Citing CS2 Flag-Smad3
Articles |
---|
Sox17 promotes cell cycle progression and inhibits TGF-beta/Smad3 signaling to initiate progenitor cell behavior in the respiratory epithelium. Lange AW, Keiser AR, Wells JM, Zorn AM, Whitsett JA. PLoS One. 2009 . 4(5):e5711. PubMed |
Sox2 is required for maintenance and differentiation of bronchiolar Clara, ciliated, and goblet cells. Tompkins DH, Besnard V, Lange AW, Wert SE, Keiser AR, Smith AN, Lang R, Whitsett JA. PLoS One. 2009 Dec 14;4(12):e8248. doi: 10.1371/journal.pone.0008248. PubMed |
USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Inui M, Manfrin A, Mamidi A, Martello G, Morsut L, Soligo S, Enzo E, Moro S, Polo S, Dupont S, Cordenonsi M, Piccolo S. Nat Cell Biol. 2011 Sep 25;13(11):1368-75. doi: 10.1038/ncb2346. PubMed |
The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-beta signaling. Nyati S, Schinske-Sebolt K, Pitchiaya S, Chekhovskiy K, Chator A, Chaudhry N, Dosch J, Van Dort ME, Varambally S, Kumar-Sinha C, Nyati MK, Ray D, Walter NG, Yu H, Ross BD, Rehemtulla A. Sci Signal. 2015 Jan 6;8(358):ra1. doi: 10.1126/scisignal.2005379. PubMed |
Iron-induced Local Complement Component 3 (C3) Up-regulation via Non-canonical Transforming Growth Factor (TGF)-beta Signaling in the Retinal Pigment Epithelium. Li Y, Song D, Song Y, Zhao L, Wolkow N, Tobias JW, Song W, Dunaief JL. J Biol Chem. 2015 May 8;290(19):11918-34. doi: 10.1074/jbc.M115.645903. Epub 2015 Mar 23. PubMed |
SMAD family member 3 (SMAD3) and SMAD4 repress HIF2alpha-dependent iron-regulatory genes. Ma X, Das NK, Castillo C, Gourani A, Perekatt AO, Verzi MP, Shah YM. J Biol Chem. 2019 Mar 15;294(11):3974-3986. doi: 10.1074/jbc.RA118.005549. Epub 2019 Jan 18. PubMed |
NHC-gold compounds mediate immune suppression through induction of AHR-TGFbeta1 signalling in vitro and in scurfy mice. Cheng X, Haeberle S, Shytaj IL, Gama-Brambila RA, Theobald J, Ghafoory S, Wolker J, Basu U, Schmidt C, Timm A, Taskova K, Bauer AS, Hoheisel J, Tsopoulidis N, Fackler OT, Savarino A, Andrade-Navarro MA, Ott I, Lusic M, Hadaschik EN, Wolfl S. Commun Biol. 2020 Jan 3;3:10. doi: 10.1038/s42003-019-0716-8. eCollection 2020. PubMed |
pVHL-mediated SMAD3 degradation suppresses TGF-beta signaling. Zhou J, Dabiri Y, Gama-Brambila RA, Ghafoory S, Altinbay M, Mehrabi A, Golriz M, Blagojevic B, Reuter S, Han K, Seidel A, Dikic I, Wolfl S, Cheng X. J Cell Biol. 2022 Jan 3;221(1):e202012097. doi: 10.1083/jcb.202012097. Epub 2021 Dec 3. PubMed |
SMAD3 mutation in LDS3 causes bone fragility by impairing the TGF-beta pathway and enhancing osteoclastogenesis. El-Gazzar A, Kang H, Fratzl-Zelman N, Webb E, Barnes AM, Jovanovic M, Mehta SG, Datta V, Saraff V, Dale RK, Rauch F, Marini JC, Hogler W. Bone Rep. 2022 Jul 16;17:101603. doi: 10.1016/j.bonr.2022.101603. eCollection 2022 Dec. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.